Linical Co., Ltd. (TYO:2183)

Japan flag Japan · Delayed Price · Currency is JPY
317.00
+3.00 (0.96%)
At close: Feb 6, 2026
-5.93%
Market Cap7.16B -11.9%
Revenue (ttm)9.87B -15.4%
Net Income-1.19B
EPS-52.51
Shares Out22.59M
PE Ration/a
Forward PEn/a
Dividend16.00 (5.05%)
Ex-Dividend DateMar 30, 2026
Volume18,300
Average Volume34,375
Open314.00
Previous Close314.00
Day's Range312.00 - 318.00
52-Week Range258.00 - 363.00
Beta0.22
RSI58.63
Earnings DateFeb 13, 2026

About Linical

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 598
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2183
Full Company Profile

Financial Performance

Financial Statements